Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6TWC

Crystal Structure of the Catalytic Domain of the Coagulation Factor XIa in Complex with Double Bridged Peptide F21

Summary for 6TWC
Entry DOI10.2210/pdb6twc/pdb
DescriptorCoagulation factor XI, Double Bridged Peptide F21, ACETONE, ... (4 entities in total)
Functional Keywordsprotease, coagulation factors, inhibitor, double bridged peptide, phage display, blood clotting
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains3
Total formula weight31304.73
Authors
Kong, X.D.,Pojer, F.,Heinis, C. (deposition date: 2020-01-13, release date: 2020-05-20, Last modification date: 2024-01-24)
Primary citationKong, X.D.,Moriya, J.,Carle, V.,Pojer, F.,Abriata, L.A.,Deyle, K.,Heinis, C.
De novo development of proteolytically resistant therapeutic peptides for oral administration.
Nat Biomed Eng, 4:560-571, 2020
Cited by
PubMed Abstract: The oral administration of peptide drugs is hampered by their metabolic instability and limited intestinal uptake. Here, we describe a method for the generation of small target-specific peptides (less than 1,600 Da in size) that resist gastrointestinal proteases. By using phage display to screen large libraries of genetically encoded double-bridged peptides on protease-resistant fd bacteriophages, we generated a peptide inhibitor of the coagulation Factor XIa with nanomolar affinity that resisted gastrointestinal proteases in all regions of the gastrointestinal tract of mice after oral administration, enabling more than 30% of the peptide to remain intact, and small quantities of it to reach the blood circulation. We also developed a gastrointestinal-protease-resistant peptide antagonist for the interleukin-23 receptor, which has a role in the pathogenesis of Crohn's disease and ulcerative colitis. The de novo generation of targeted peptides that resist proteolytic degradation in the gastrointestinal tract should help the development of effective peptides for oral delivery.
PubMed: 32393891
DOI: 10.1038/s41551-020-0556-3
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.86 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon